ArticleCancer immunology, immunotherapy : CII2022

Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia.

Fernanda Marconi Roversi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.